SUPN
Supernus Pharmaceuticals Inc
Price:  
32.47 
USD
Volume:  
1,197,330.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN DCF Valuation - Growth Exit 5Y

25.2%
Upside

What is the DCF valuation of SUPN??

The Discounted Cash Flow (DCF) valuation of Supernus Pharmaceuticals Inc (SUPN) is 40.64 USD. With the latest stock price at 32.47 USD, the upside of Supernus Pharmaceuticals Inc based on DCF is 25.2%.

Is SUPN a buy or a sell?

Based on the latest price of 32.47 USD and our DCF valuation, Supernus Pharmaceuticals Inc (SUPN) is a buy. buying SUPN stocks now will result in a potential gain of 25.2%.

Range Selected
WACC / Discount Rate 6.2% - 7.6% 6.9%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price 27.35 - 89.37 40.64
Upside -15.8% - 175.2% 25.2%
32.47 USD
Stock Price
40.64 USD
Fair Price